. 2019 Jan; 13(1):24-31.
doi: 10.1007/s11684-019-0679-7.

Screening responsive or resistant biomarkers of immune checkpoint inhibitors based on online databases

Zhen Xiang 1 Yingyan Yu 2 
  • PMID: 30659409
  •     64 References
  •     1 citations


Immune checkpoint inhibitors are a promising strategy in the treatment of cancer, especially advanced types. However, not all patients are responsive to immune checkpoint inhibitors. The response rate depends on the immune microenvironment, tumor mutational burden (TMB), expression level of immune checkpoint proteins, and molecular subtypes of cancers. Along with the Cancer Genome Project, various open access databases, including The Cancer Genome Atlas and Gene Expression Omnibus, provide large volumes of data, which allow researchers to explore responsive or resistant biomarkers of immune checkpoint inhibitors. In this review, we introduced some methodologies on database selection, biomarker screening, current progress of immune checkpoint blockade in solid tumor treatment, possible mechanisms of drug resistance, strategies of overcoming resistance, and indications for immune checkpoint inhibitor therapy.

Keywords: data mining; immune checkpoint blockade; resistance; sensitivity.

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
G J Freeman, A J Long, +16 authors, T Honjo.
J Exp Med, 2000 Oct 04; 192(7). PMID: 11015443    Free PMC article.
Highly Cited.
Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Karen L Grogg, Christine M Lohse, +2 authors, Thomas C Smyrk.
Mod Pathol, 2003 Jul 16; 16(7). PMID: 12861059
Adjusting batch effects in microarray expression data using empirical Bayes methods.
W Evan Johnson, Cheng Li, Ariel Rabinovic.
Biostatistics, 2006 Apr 25; 8(1). PMID: 16632515
Highly Cited.
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
Manish J Butte, Mary E Keir, +2 authors, Gordon J Freeman.
Immunity, 2007 Jul 17; 27(1). PMID: 17629517    Free PMC article.
Highly Cited.
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
Jang-June Park, Ryusuke Omiya, +11 authors, Koji Tamada.
Blood, 2010 May 18; 116(8). PMID: 20472828    Free PMC article.
Highly Cited.
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.
Chrystelle Brignone, Maya Gutierrez, +9 authors, Frédéric Triebel.
J Transl Med, 2010 Jul 27; 8. PMID: 20653948    Free PMC article.
The blockade of immune checkpoints in cancer immunotherapy.
Drew M Pardoll.
Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437870    Free PMC article.
Highly Cited. Review.
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, +12 authors, Nikolaus Schultz.
Cancer Discov, 2012 May 17; 2(5). PMID: 22588877    Free PMC article.
Highly Cited.
Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis.
Peter Kupfer, Reinhard Guthke, +3 authors, Raimund W Kinne.
BMC Med Genomics, 2012 Jun 12; 5. PMID: 22682473    Free PMC article.
Macrophage regulation of tumor responses to anticancer therapies.
Michele De Palma, Claire E Lewis.
Cancer Cell, 2013 Mar 23; 23(3). PMID: 23518347
Highly Cited. Review.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Christine Feig, James O Jones, +12 authors, Douglas T Fearon.
Proc Natl Acad Sci U S A, 2013 Nov 28; 110(50). PMID: 24277834    Free PMC article.
Highly Cited.
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.
KiBem Kim, Andrew D Skora, +8 authors, Shibin Zhou.
Proc Natl Acad Sci U S A, 2014 Jul 30; 111(32). PMID: 25071169    Free PMC article.
Highly Cited.
Immune escape mechanisms as a guide for cancer immunotherapy.
Gregory L Beatty, Whitney L Gladney.
Clin Cancer Res, 2014 Dec 17; 21(4). PMID: 25501578    Free PMC article.
Highly Cited. Review.
The future of immune checkpoint therapy.
Padmanee Sharma, James P Allison.
Science, 2015 Apr 04; 348(6230). PMID: 25838373
Highly Cited. Review.
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.
Lieping Chen, Xue Han.
J Clin Invest, 2015 Sep 02; 125(9). PMID: 26325035    Free PMC article.
Highly Cited. Review.
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Eliezer M Van Allen, Diana Miao, +19 authors, Levi A Garraway.
Science, 2015 Sep 12; 350(6257). PMID: 26359337    Free PMC article.
Highly Cited.
Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis.
Xuechao Liu, Jianjun Liu, +9 authors, Xiaowei Sun.
BMC Cancer, 2015 Oct 27; 15. PMID: 26498209    Free PMC article.
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial.
Amandine Legat, Hélène Maby-El Hajjami, +15 authors, Daniel E Speiser.
Clin Cancer Res, 2015 Oct 27; 22(6). PMID: 26500235
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, +16 authors, Edward B Garon.
Lancet, 2015 Dec 30; 387(10027). PMID: 26712084
Highly Cited.
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.
Weiping Zou, Jedd D Wolchok, Lieping Chen.
Sci Transl Med, 2016 Mar 05; 8(328). PMID: 26936508    Free PMC article.
Highly Cited. Review.
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, +33 authors, Charles Swanton.
Science, 2016 Mar 05; 351(6280). PMID: 26940869    Free PMC article.
Highly Cited.
A phase I study of indoximod in patients with advanced malignancies.
Hatem H Soliman, Susan E Minton, +13 authors, Scott J Antonia.
Oncotarget, 2016 Mar 24; 7(16). PMID: 27008709    Free PMC article.
Highly Cited.
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Jonathan M Pitt, Marie Vétizou, +8 authors, Laurence Zitvogel.
Immunity, 2016 Jun 23; 44(6). PMID: 27332730
Highly Cited. Review.
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma.
Maria Libera Ascierto, Tracee L McMiller, +12 authors, Suzanne L Topalian.
Cancer Immunol Res, 2016 Aug 06; 4(9). PMID: 27491898    Free PMC article.
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, +16 authors, KEYNOTE-024 Investigators.
N Engl J Med, 2016 Oct 11; 375(19). PMID: 27718847
Highly Cited.
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody.
Neil H Segal, Theodore F Logan, +17 authors, Ronald Levy.
Clin Cancer Res, 2016 Nov 01; 23(8). PMID: 27756788
Highly Cited.
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas.
Aaron Goodman, Sandip P Patel, Razelle Kurzrock.
Nat Rev Clin Oncol, 2016 Nov 03; 14(4). PMID: 27805626
Highly Cited. Review.
Identification of a prognostic 5-Gene expression signature for gastric cancer.
Jun-Yi Hou, Yu-Gang Wang, +2 authors, Qian-Ping Li.
J Cancer Res Clin Oncol, 2016 Dec 31; 143(4). PMID: 28035468
Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
Muhammad Tariq, Jieqiong Zhang, +3 authors, Bo Yang.
J Cell Biochem, 2017 Jan 21; 118(9). PMID: 28106295
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Willy Hugo, Jesse M Zaretsky, +15 authors, Roger S Lo.
Cell, 2017 Jan 28; 168(3). PMID: 28129544
Highly Cited.
Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy.
Xianda Zhao, Subbaya Subramanian.
Cancer Res, 2017 Feb 06; 77(4). PMID: 28159861
Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy.
Maria L Ascierto, Alvin Makohon-Moore, +18 authors, Suzanne L Topalian.
Clin Cancer Res, 2017 Feb 15; 23(12). PMID: 28193624    Free PMC article.
Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit.
Ahmad A Tarhini, Yan Lin, +4 authors, Lana Hamieh.
Oncoimmunology, 2017 Mar 28; 6(2). PMID: 28344862    Free PMC article.
Masterful Antibodies: Checkpoint Blockade.
Nils Lonberg, Alan J Korman.
Cancer Immunol Res, 2017 Apr 05; 5(4). PMID: 28373215
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.
Aleix Prat, Alejandro Navarro, +17 authors, Enriqueta Felip.
Cancer Res, 2017 May 11; 77(13). PMID: 28487385
Highly Cited.
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, +43 authors, Luis A Diaz.
Science, 2017 Jun 10; 357(6349). PMID: 28596308    Free PMC article.
Highly Cited.
Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment? A matched comparison study of the French Surgical Association (AFC).
P Duconseil, J Périnel, +12 authors, O Turrini.
Eur J Surg Oncol, 2017 Jul 09; 43(9). PMID: 28687431
A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer.
Wenbo Yao, Qian Ba, +8 authors, Hui Wang.
EBioMedicine, 2017 Jul 30; 22. PMID: 28754304    Free PMC article.
Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.
Kazuto Harada, Xiaochuan Dong, +11 authors, Jaffer A Ajani.
Gastric Cancer, 2017 Aug 13; 21(1). PMID: 28801853
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Danju Luo, Bin Deng, +2 authors, Xiu Nie.
Artif Cells Nanomed Biotechnol, 2017 Aug 25; 46(6). PMID: 28835135
Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Shotaro Korehisa, Eiji Oki, +6 authors, Yoshihiko Maehara.
Int J Cancer, 2017 Oct 19; 142(4). PMID: 29044503
Cardiotoxicity of immune checkpoint inhibitors.
Gilda Varricchi, Maria Rosaria Galdiero, +5 authors, Carlo Gabriele Tocchetti.
ESMO Open, 2017 Nov 07; 2(4). PMID: 29104763    Free PMC article.
Highly Cited. Review.
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.
Yelena Y Janjigian, Francisco Sanchez-Vega, +37 authors, Nikolaus Schultz.
Cancer Discov, 2017 Nov 11; 8(1). PMID: 29122777    Free PMC article.
Highly Cited.
Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.
Charny Park, Junhun Cho, +15 authors, Kyoung-Mee Kim.
Oncoimmunology, 2017 Nov 18; 6(11). PMID: 29147610    Free PMC article.
Molecular classification and precision therapy of cancer: immune checkpoint inhibitors.
Yingyan Yu.
Front Med, 2017 Dec 07; 12(2). PMID: 29209918
Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
Bangrong Cao, Qifeng Wang, +2 authors, Jinyi Lang.
Oncoimmunology, 2018 Jan 09; 7(2). PMID: 29308323    Free PMC article.
Text Mining of Rheumatoid Arthritis and Diabetes Mellitus to Understand the Mechanisms of Chinese Medicine in Different Diseases with Same Treatment.
Ning Zhao, Guang Zheng, +6 authors, Ai-Ping Lu.
Chin J Integr Med, 2018 Jan 13; 24(10). PMID: 29327123
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination.
Francesco Fiorica, Lorenzo Belluomini, +4 authors, Antonio Frassoldati.
Am J Clin Oncol, 2018 Feb 02; 41(11). PMID: 29389733
Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.
Xiaofang Xing, Jianping Guo, +23 authors, Jiafu Ji.
Oncoimmunology, 2018 Feb 06; 7(3). PMID: 29399387    Free PMC article.
Highly Cited.
Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
Run Tian, Xiaofang Li, +3 authors, Kunzheng Wang.
Int J Oncol, 2018 Feb 14; 52(4). PMID: 29436615    Free PMC article.
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
Chia-Wei Li, Seung-Oe Lim, +25 authors, Mien-Chie Hung.
Cancer Cell, 2018 Feb 14; 33(2). PMID: 29438695    Free PMC article.
Highly Cited.
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.
Heinz Läubli, Philipp Müller, +3 authors, Alfred Zippelius.
Cancer Immunol Immunother, 2018 Mar 01; 67(5). PMID: 29487979
Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment.
Antje Tunger, Maximilian Kießler, +4 authors, Marc Schmitz.
Biomedicines, 2018 Mar 02; 6(1). PMID: 29494517    Free PMC article.
A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Xiaogang Mao, Xiaomin Qin, +7 authors, Hui Xing.
Gynecol Oncol, 2018 Mar 12; 149(1). PMID: 29525275
Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Marina A Pereira, Marcus F K P Ramos, +7 authors, Ulysses Ribeiro.
J Surg Oncol, 2018 Mar 14; 117(5). PMID: 29534305
Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Peng Wu, Jia-Li Liu, +4 authors, Song Wu.
BMC Cancer, 2018 Mar 15; 18(1). PMID: 29534679    Free PMC article.
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade.
David A Schaer, Richard P Beckmann, +19 authors, Michael Kalos.
Cell Rep, 2018 Mar 15; 22(11). PMID: 29539425
Highly Cited.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Matthew D Hellmann, Tudor-Eliade Ciuleanu, +21 authors, Luis Paz-Ares.
N Engl J Med, 2018 Apr 17; 378(22). PMID: 29658845    Free PMC article.
Highly Cited.
TGF-β Inhibition and Immunotherapy: Checkmate.
Karuna Ganesh, Joan Massagué.
Immunity, 2018 Apr 19; 48(4). PMID: 29669246    Free PMC article.
Highly Cited.
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
Matthew D Hellmann, Margaret K Callahan, +13 authors, Scott J Antonia.
Cancer Cell, 2018 May 08; 33(5). PMID: 29731394    Free PMC article.
Highly Cited.
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Seung Tae Kim, Razvan Cristescu, +20 authors, Won Ki Kang.
Nat Med, 2018 Jul 18; 24(9). PMID: 30013197
Highly Cited.
Somatic mutation, cellular differentiation, and cancer causation.
D S Straus.
J Natl Cancer Inst, 1981 Aug 01; 67(2). PMID: 7021938
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
M F Krummel, J P Allison.
J Exp Med, 1995 Aug 01; 182(2). PMID: 7543139    Free PMC article.
Highly Cited.
Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways.
Zhen Xiang, Zhijun Zhou, +11 authors, Yingyan Yu.
Oncogene, 2021 Jun 28; 40(31). PMID: 34175886    Free PMC article.